Literature DB >> 5569152

The effect of surgical lesions to frontal cortex and substantia nigra on amphetamine responses in rats.

S D Iversen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5569152     DOI: 10.1016/0006-8993(71)90184-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


× No keyword cloud information.
  7 in total

1.  Lesions of the frontal cortex of the rat: changes in neurotransmitter systems in sub-cortical regions [proceedings].

Authors:  C J Carter; C J Pycock
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

2.  Shifting of the d-amphetamine dose-response curve in rats with frontal cortical ablations.

Authors:  S D Glick; R G Marsanico
Journal:  Psychopharmacologia       Date:  1974-04-08

Review 3.  Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia.

Authors:  A A Grace
Journal:  J Neural Transm Gen Sect       Date:  1993

4.  Remediation of attentional dysfunction in rats with lesions of the medial prefrontal cortex by intra-accumbens administration of the dopamine D(2/3) receptor antagonist sulpiride.

Authors:  Marie A Pezze; Jeffrey W Dalley; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2008-11-05       Impact factor: 4.530

5.  Changes in morphine self-administration after brainstem lesions in rats.

Authors:  S D Glick; R D Cox
Journal:  Psychopharmacology (Berl)       Date:  1977-04-29       Impact factor: 4.530

6.  Effect of ventral noradrenergic bundle lesions on concentrations of monoamine neurotransmitters and metabolites in several discrete areas of the rat brain.

Authors:  C A Johnston; L A Mattiace; A Negro-Vilar
Journal:  Cell Mol Neurobiol       Date:  1987-12       Impact factor: 5.046

7.  Pars compacta of the substantia nigra modulates motor activity but is not involved importantly in regulating food and water intake.

Authors:  G K Hodge; L L Butcher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-08       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.